SLC7A5 and Hyperphenylalaninemia: In our cellular experiments, carriers of the SLC7A5 variant exhibited hyperphenylalaninemia-related upregulation of the LAT1 transporter, accompanied by a corresponding decrease in transcriptomic activity of both the cellular proteasome complex and the FOXO signalling pathway.